Semaglutide helps reduce risk of heart attack, stroke in people without diabetes, study finds - ABC News

Semaglutide is the main ingredient in Wegovy and Ozempic. A recent study found it may help reduce the risk of heart attack and stroke in people without diabetes.
Semaglutide is the main ingredient in medications including Wegovy and Ozempic.
ABC News’ Dr. Jennifer Ashton explains a new study in the New England Journal of Medicine that shows a reduction in heart attacks, strokes and death in overweight or obese participants who took semaglutide.

Semaglutide can protect you from the risk of heart attack too, says study

The weight-loss drug Wegovy lowered heart attack risk in a large trial

Wegovy May Reduce Risk of Heart Attack, Stroke

Semaglutide helps reduce risk of heart attack, stroke in people without diabetes, study finds - ABC News

Danielle Belardo, M.D. on Instagram: HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of cardiovascular death, heart attack, stroke, heart failure, AND

Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention

Remote Health Solutions

Weight-loss drug Wegovy produces 'largest benefit ever seen' for patients with most common form of heart failure, trial finds, Health

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial, Cardiovascular Diabetology

Weight-loss drug Wegovy cuts heart attack, stroke risk by 20%, study says

Neuralert

Danielle Belardo, M.D. on Instagram: HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of cardiovascular death, heart attack, stroke, heart failure, AND

Semaglutide helps reduce risk of heart attack, stroke in people without diabetes, study finds - ABC News